sb 203580 has been researched along with nickel chloride in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (nickel chloride) | Trials (nickel chloride) | Recent Studies (post-2010) (nickel chloride) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 725 | 2 | 170 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aiba, S; Manome, H; Mizuashi, M; Mollah, ZU; Nakagawa, S; Ohtani, T; Tagami, H; Yoshino, Y | 1 |
1 other study(ies) available for sb 203580 and nickel chloride
| Article | Year |
|---|---|
p38 Mitogen-activated protein kinase and extracellular signal-regulated kinases play distinct roles in the activation of dendritic cells by two representative haptens, NiCl2 and 2,4-dinitrochlorobenzene.
Topics: Antigens, CD; B7-2 Antigen; Cytokines; Dendritic Cells; Dinitrochlorobenzene; Enzyme Inhibitors; Flavonoids; Humans; I-kappa B Proteins; Imidazoles; Membrane Glycoproteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Monocytes; NF-kappa B; Nickel; p38 Mitogen-Activated Protein Kinases; Phenotype; Phosphorylation; Pyridines; RNA, Messenger | 2003 |